Renalytix announces accepted abstracts at upcoming ADA, AANP conferences

Renalytix announced that three scientific abstracts have been accepted at the upcoming American Diabetes Association, ADA, 83rd Scientific Sessions in San Diego, California and another abstract has been accepted at the American Association of Nurse Practitioners, AANP, National Conference in New Orleans, Louisiana. American Diabetes Association 83rd Scientific Sessions presentations will be displayed over three days June 24-26, 2023: Late-breaker Presentation: “Clinical Impact of Risk Profiling with KidneyIntelX on DKD Progression in a Large Integrated Health Care System.” Poster presentation: “Extended Validation of KidneyIntelX(TM) in Diabetic Kidney Disease.” Poster presentation: “Cost of Care for Patients with Diabetic Kidney Disease in Veterans Health Administration.” An American Association of Nurse Practitioner conference presentation will be displayed June 22-24, 2023, and moderated over three days: Poster presentation: “Understanding Patient Receptivity Towards Receipt of Prognostic Risk Score for Diabetic Kidney Disease” will be presented by Renalytix on behalf of the Patient Care Navigation Team at Mount Sinai Health System and focused on the significant impact KidneyIntelX can have on patients’ enhanced understanding of kidney disease and motivation to make lifestyle changes, as well as the role nurse practitioners play in influencing patient behavior and clinical outcomes.